236 related articles for article (PubMed ID: 37452490)
21. Epstein-Barr Virus Coinfection in COVID-19.
Nadeem A; Suresh K; Awais H; Waseem S
J Investig Med High Impact Case Rep; 2021; 9():23247096211040626. PubMed ID: 34428954
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
[TBL] [Abstract][Full Text] [Related]
23. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report.
Li M; Li F; Dai Y; Zeng YZ; Chen X
Front Immunol; 2024; 15():1371490. PubMed ID: 38686382
[TBL] [Abstract][Full Text] [Related]
24. Serious consequences of Epstein-Barr virus infection: Hemophagocytic lymphohistocytosis.
Xu L; Guo X; Guan H
Int J Lab Hematol; 2022 Feb; 44(1):74-81. PubMed ID: 34709704
[TBL] [Abstract][Full Text] [Related]
25. Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV Infection.
Gianella S; Anderson CM; Var SR; Oliveira MF; Lada SM; Vargas MV; Massanella M; Little SJ; Richman DD; Strain MC; Pérez-Santiago J; Smith DM
J Virol; 2016 Apr; 90(8):3944-3952. PubMed ID: 26842469
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr Virus and Human Herpesvirus-6 Reactivation in Acute COVID-19 Patients.
Brooks B; Tancredi C; Song Y; Mogus AT; Huang MW; Zhu H; Phan TL; Zhu H; Kadl A; Woodfolk J; Jerome KR; Zeichner SL
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146679
[TBL] [Abstract][Full Text] [Related]
27. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
28. Haemophagocytic lymphohistiocytosis following a COVID-19 infection: case report.
Soldera J; Bosi GR
J Infect Dev Ctries; 2023 Mar; 17(3):302-303. PubMed ID: 37023430
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis complicated by neurological involvement in a patient with dermatomyositis: A case report and literature review.
Xu T; Xiong L; Tang L
Mod Rheumatol Case Rep; 2023 Jan; 7(1):293-297. PubMed ID: 35861298
[TBL] [Abstract][Full Text] [Related]
30. Hemophagocytic lymphohistiocytosis secondary to Epstein Barr virus and Leishmania co-infection in a toddler.
DomInguez-Pinilla N; Baro-Fernández M; González-Granado LI
J Postgrad Med; 2015; 61(1):44-5. PubMed ID: 25511219
[TBL] [Abstract][Full Text] [Related]
31. Hemophagocytic Lymphohistiocytosis in Renal Transplant Recipients: A 2-Case Report.
Mascia G; Argiolas D; Carta E; Ibba S; Piredda GB
Transplant Proc; 2020 Jun; 52(5):1566-1569. PubMed ID: 32389490
[TBL] [Abstract][Full Text] [Related]
32. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis.
Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME
J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871
[TBL] [Abstract][Full Text] [Related]
33. Development of a screening score for Hemophagocytic Lymphohistiocytosis among pediatric patients with acute infection of Epstein-Barr virus.
Li X; Yan H; Xiao Z; Luo T; Xie L; Yang Y; Gong L; Tang Z; Huang J; Zhang X; Zheng M; Yao Z; Zang P; Zhu D; Lu X
Front Immunol; 2022; 13():981251. PubMed ID: 36172365
[TBL] [Abstract][Full Text] [Related]
34. The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.
Smith MC; Cohen DN; Greig B; Yenamandra A; Vnencak-Jones C; Thompson MA; Kim AS
Int J Clin Exp Pathol; 2014; 7(9):5738-49. PubMed ID: 25337215
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation.
Navarro-Bielsa A; Gracia-Cazaña T; Aldea-Manrique B; Abadías-Granado I; Ballano A; Bernad I; Gilaberte Y
An Bras Dermatol; 2023; 98(3):347-354. PubMed ID: 36803914
[TBL] [Abstract][Full Text] [Related]
36. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
[TBL] [Abstract][Full Text] [Related]
37. Rapidly Fatal Hemophagocytic Lymphohistiocytosis Developing Within Six Days Following Deceased-Donor Renal Transplantation: Case Report.
Filippone EJ; Singh P; Frank AM; Gupta A; Farber JL
Transplant Proc; 2016 Nov; 48(9):3123-3127. PubMed ID: 27932162
[TBL] [Abstract][Full Text] [Related]
38. Acute fibrinous and organizing pneumonia complicated with hemophagocytic lymphohistiocytosis caused by chronic active Epstein-Barr virus infection: a case report.
Wu X; Wang K; Gao Y; Cai Y; Wang W; Zhong D; Zhan Q
BMC Infect Dis; 2021 Dec; 21(1):1207. PubMed ID: 34863102
[TBL] [Abstract][Full Text] [Related]
39. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab.
Kato M; Lee S; Morishita T; Fujita K; Tagami A; Araki H; Sugihara JI
J Infect Chemother; 2022 Jun; 28(6):823-827. PubMed ID: 35135708
[TBL] [Abstract][Full Text] [Related]
40. Hyperinflammatory syndrome in a paediatric patient with a recent diagnosis of HIV/AIDS infection: hemophagocytic lymphohistiocytosis or immune reconstitution syndrome?
Leone F; Cotugno N; Casamento Tumeo C; Zangari P; Palomba P; Adorisio R; De Benedetti F; Bracaglia C; Papoff P; Ajassa C; Palma P; Bernardi S
BMC Infect Dis; 2023 Jul; 23(1):477. PubMed ID: 37464267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
